🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to understand the behavior of posaconazol gives as...
Status
Unknown
Location
UZ Leuven Gasthuisberg
Start Date
2014-01
Trial ID
NCT02048345
Treatments Being Tested
The primary objective of Parts 1 and 2 of the study were to establish the h...
Status
Completed
Location
Azienda Ospedaliera Universitaria Policlinico G. Martino
Start Date
2013-04
Trial ID
NCT01761292
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and pharmac...
Status
Completed
Location
Universitair Ziekenhuis Gent ( Site 0001)
Start Date
2017-11-10
Trial ID
NCT03326986
The goal of Parts A and B of this Phase 1/2, first-in-human, randomized stu...
Status
Completed
Location
University of Florida College of Medicine
Start Date
2022-10-31
Trial ID
NCT05781399
Treatments Being Tested
This study will estimate the relative bioavailability of AZD5055 film-coate...
Status
Completed
Location
Research Site
Start Date
2022-11-04
Trial ID
NCT05630677
The purpose of the study is to assess the safety and tolerability of AZD679...
Status
Completed
Location
Research Site
Start Date
2022-12-05
Trial ID
NCT05662033
The primary objective of this study is to assess the pharmacokinetic profil...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-01-20
Trial ID
NCT00938275
Treatments Being Tested
The primary objective of the study was to evaluate the safety and tolerabil...
Status
Completed
Location
OPTIMED Clinical Research
Start Date
2011-12
Trial ID
NCT02186002
Researchers are looking for a better way to treat heart failure, a conditio...
Status
Completed
Location
SocraTec R&D GmbH
Start Date
2021-10-12
Trial ID
NCT05086952
The primary purpose of this study is to evaluate the safety and tolerabilit...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2011-11
Trial ID
NCT01499017
Treatments Being Tested